DDrare: Database of Drug Development for Rare Diseases

Searched query = "Huge arteriovenous malformation with cervicofacial or limb lesion", "Huge arteriovenous malformation", "Arteriovenous malformation"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = 68Ga-NEB; Bevacizumab; Bleomycin; Dexmedetomidine; Dexmedetomidine 1; Dexmedetomidine 2; Dexmedetomidine 3; Doxycycline; Ethanol; Heparin; Heparin Sodium; L04AA10; Lipiodol; Lipiodol® Ultra Fluid with surgical glues; Lovastatin; Mekinist; Minocycline; Other: normal saline; RAPAMUNE; Rapamune; SIROLIMUS; Sirolimus; Sirolimus 0,1% crème; Sirolimus 1mg/mL; Sufentanil; Thalidomide

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02314377 (ClinicalTrials.gov)	June 2016	25/11/2014	Bevacizumab Therapy for Brain Arteriovenous Malformation	Bevacizumab Therapy for Brain Arteriovenous Malformation	Brain Arteriovenous Malformation	Drug: Bevacizumab	University of California, San Francisco	NULL	Completed	18 Years	64 Years	All	2	Phase 1	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02314377
(ClinicalTrials.gov)

June 2016

25/11/2014

Bevacizumab Therapy for Brain Arteriovenous Malformation

Brain Arteriovenous Malformation

Drug: Bevacizumab

University of California, San Francisco

NULL

Completed

18 Years

64 Years

All

Phase 1

United States